+ copy+Line Copy 7

University of California San Francisco

Give to UCSF
250 Results in the UCSF News Center
Type of Article
Areas of Focus
Date of Publication
Health And Science Topics
Campus Topics

Gene Variant Explains Differences in Diabetes Drug Response

The first results from a large international study of patients taking metformin, the world’s most commonly used type 2 diabetes drug, reveal genetic differences among patients that may explain why some respond much better to the drug than others.

Covert Inflammation May Trigger Many Forms of Cancer

A previously unidentifiable type of low-grade inflammation may explain why common anti-inflammatory drugs such as aspirin have shown promise against some types of cancer – even when patients don’t display typical signs of inflammation.

Keeping the Heart’s Electrical System Running

A drug commonly used to treat high blood pressure has been shown to significantly reduce the risk of blocked electrical impulses to the heart and could be an effective treatment for certain types of heart disease known as conduction disease, in which the progression of electrical impulses through the heart is impeded.

Hybrid Cancer Drug Could Be Resistance-Resistant

A team of cancer researchers led by scientists at UCSF and Memorial Sloan Kettering Cancer Center in New York have developed a first-of-its-kind hybrid drug with the power to outsmart drug-resistant cancers.

Wrapping Up Multiple Sclerosis

With one drug to shut down its progression and another to undo its damage, plus a worldwide effort stalking the origins of multiple sclerosis, MS doesn’t stand a chance.

Tricked-Out Immune Cells Could Attack Cancer, Spare Healthy Cells

UCSF scientists have created a new class of highly customizable biological sensors that can be used to form “logic gates” inside cells of the immune system, giving these cells the capability to home in on and kill a wide range of cancer cells while preventing them from attacking normal tissue.

Placeholder image